We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$222M
AUM Growth
-$46.5M
Cap. Flow
-$112M
Cap. Flow %
-50.26%
Top 10 Hldgs %
33.68%
Holding
145
New
30
Increased
29
Reduced
20
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 24%
2 Healthcare 13.18%
3 Financials 3.13%
4 Consumer Discretionary 2.88%
5 Industrials 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMKR
1
DELISTED
Emcore Corp
EMKR
$5.94M 2.67%
79,371
PDFS icon
2
PDF Solutions
PDFS
$2.13B
$5.67M 2.55%
246,231
+38,488
+19% +$793K
SIMO icon
3
Silicon Motion
SIMO
$9.19B
$5.34M 2.4%
+77,434
New +$5.47M
AVNW icon
4
Aviat Networks
AVNW
$262M
$4.57M 2.05%
138,974
PLAB icon
5
Photronics
PLAB
$1.79B
$4.52M 2.03%
331,669
+20,000
+6% +$271K
CYBE
6
DELISTED
Cyberoptics Corp
CYBE
$4.15M 1.87%
116,566
+12,426
+12% +$506K
GRTX
7
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$3.83M 1.72%
472,180
+3,006
+0.6% +$25.8K
OIIM
8
DELISTED
02Micro International
OIIM
$3.68M 1.66%
609,737
+144,568
+31% +$969K
ADTN icon
9
Adtran
ADTN
$798M
$3.54M 1.59%
+188,738
New +$3.97M
ADMS
10
DELISTED
Adamas Pharmaceuticals
ADMS
$3.1M 1.39%
625,080
+34,350
+6% +$167K
CVNA icon
11
Carvana
CVNA
$43.3B
$3.04M 1.37%
50,445
AVEO
12
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.81M 1.26%
+454,364
New +$2.72M
DZSI
13
DELISTED
DZS Inc. Common Stock
DZSI
$2.71M 1.22%
221,492
-31,260
-12% -$492K
THER
14
DELISTED
THERATECHNOLOGIES INC COM
THER
$2.66M 1.2%
708,047
-143,366
-17% -$538K
PDSB icon
15
PDS Biotechnology
PDSB
$38.1M
$2.65M 1.19%
177,589
-171,114
-49% -$2.13M
ENV
16
DELISTED
ENVESTNET, INC.
ENV
$2.5M 1.12%
31,120
SILC icon
17
Silicom
SILC
$228M
$2.35M 1.06%
54,325
-2,994
-5% -$129K
HGV icon
18
Hilton Grand Vacations
HGV
$3.84B
$2.18M 0.98%
+45,759
New +$1.94M
CDLX icon
19
Cardlytics
CDLX
$21M
$2.13M 0.96%
2,535
+110
+5% +$112K
OMF icon
20
OneMain Financial
OMF
$6.9B
$2.05M 0.92%
36,976
+910
+3% +$52.9K
XFOR icon
21
X4 Pharmaceuticals
XFOR
$363M
$2.04M 0.92%
12,883
+1,727
+15% +$284K
SCPH
22
DELISTED
scPharmaceuticals
SCPH
$2M 0.9%
300,760
+136,766
+83% +$817K
PRTK
23
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.89M 0.85%
389,440
+158,068
+68% +$871K
SCYX icon
24
SCYNEXIS
SCYX
$37M
$1.82M 0.82%
42,891
FOCL
25
EDAP TMS S.A.
FOCL
$226M
$1.81M 0.81%
283,368

Similar funds

Worth Venture Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Worth Venture Partners held 145 positions worth $222M, down 17% from $269M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Worth Venture Partners withdrew a net $112M in Q3 2021, closing 15 positions and reducing 20 holdings. Its most notable exit was Aspen Aerogels, an estimated $4.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Silicon Motion worth $5.34M.

  • Worth Venture Partners's largest Q3 2021 buy was Silicon Motion: 77,434 shares worth $5.34M.
  • Worth Venture Partners added most to 02Micro International in Q3 2021, an estimated $969K increase.
  • Worth Venture Partners's biggest Q3 2021 reduction was PDS Biotechnology, cutting an estimated $2.13M.
  • Worth Venture Partners fully exited Aspen Aerogels in Q3 2021, selling an estimated $4.39M.
  • Worth Venture Partners's ten largest holdings make up 34% of its $222M portfolio in Q3 2021.
  • Worth Venture Partners opened 30 new positions and closed 15 in Q3 2021.
  • Worth Venture Partners's portfolio value fell 17% quarter-over-quarter to $222M.

Based on Worth Venture Partners's 13F filing for Q3 2021, filed 15 Nov 2021.